Your browser doesn't support javascript.
loading
Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-ß signaling.
Li, Kai; Niu, Yi; Yuan, Yichuan; Qiu, Jiliang; Shi, Yunxing; Zhong, Chengrui; Qiu, Zhiyu; Li, Keren; Lin, Zhu; Huang, Zhenkun; Zhang, Chao; Zuo, Dinglan; He, Wei; Yuan, Yunfei; Li, Binkui.
Afiliação
  • Li K; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Niu Y; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Yuan Y; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Qiu J; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Shi Y; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Zhong C; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Qiu Z; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Li K; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Lin Z; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Huang Z; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Zhang C; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Zuo D; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • He W; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Yuan Y; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
  • Li B; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
Oncogene ; 41(23): 3197-3209, 2022 06.
Article em En | MEDLINE | ID: mdl-35501461
Thermal ablation is a main curative therapy for early-stage hepatocellular carcinoma (HCC). However, insufficient ablation has been shown to promote HCC progression. E3 ligases have been approved to play important roles in malignant tumors. Whether E3 ligases are involved in HCC progression caused by insufficient ablation remains unclear. Herein, using RNA-sequencing coupled with an in vitro loss-of-function screen, we found that the E3 ligase Neuronal Precursor cell-expressed Developmentally Downregulated 4 (Nedd4) was upregulated in HCC insufficient ablation tissues and promoted HCC cells migration. The upregulation of Nedd4 was induced by METTL14-mediated N6-methyladenosine modification after sublethal heat treatment. Knockdown of Nedd4 inhibited HCC metastasis and growth in vitro and in vivo. Mechanistically, Nedd4 enhanced TGF-ß signal transduction mediated tumor progression by directly binding to TGF-ß type I receptor (TGFBR1) and forming K27-linked ubiquitin at Lysine 391. Additionally, the adverse effect on HCC of sublethal heat treatment was mediated by Nedd4. Clinically, high Nedd4 expression was positively correlated with aggressive tumor phenotypes and poor prognosis in HCC patients. Patient-derived xenograft (PDX) model confirmed this conclusion. Collectively, this study demonstrated that Nedd4 induced by insufficient ablation plays a crucial role in promoting HCC progression and provides a novel therapeutic target for HCC.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Ubiquitina-Proteína Ligases Nedd4 / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Ubiquitina-Proteína Ligases Nedd4 / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article